Polyunsaturated fatty acids and psychotic disorders: integrating mechanistic, genetic, and clinical evidence
Laura J. Westacott, Karolina Dec, Hanna Gruszczynska, Craig Joyce, Stephanie Mitchell, Jeremy Hall, Adrian J. Harwood · 2026
Read Polyunsaturated fatty acids and psychotic disorders: integrating mechanistic, genetic, and clinical evidence by Laura J. Westacott, Karolina Dec, Hanna Gruszczynska, Craig Joyce, Stephanie Mitchell, Jeremy Hall, Adrian J. Harwood (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13625677.txt.
Description
Laura Westacott and six co-authors tie polyunsaturated fatty acids to psychotic disorders across three kinds of evidence. These fats, the omega-3 and omega-6 families, feed brain growth and supply building blocks for immune and inflammatory signals. Their 2026 review lays out the fats' brain roles first, with eyes on synaptic, immune, and stress pathways in development. Then animal and human evidence face off.
Bench work shows that altered fat supply bends brain and behavior marks tied to psychosis. Human studies — population counts, gene sets, and fat scans — tie disrupted fat metabolism to both schizophrenia and bipolar disorder. Trials of omega-3 dosing get a frank grade: promise in spots, limits overall. Fat pathways may bridge growth, immunity, and risk, and serve as drug targets, they hold.
Catalog record
| CREATOR | Laura J. Westacott, Karolina Dec, Hanna Gruszczynska, Craig Joyce, Stephanie Mitchell, Jeremy Hall, Adrian J. Harwood |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 118 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |